{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:59:32Z","timestamp":1789444772280,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00430-016-0483-9","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T15:02:59Z","timestamp":1476802979000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route"],"prefix":"10.1007","volume":"206","author":[{"given":"Imran","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Moir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"H\u00e9raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dimier-Poisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"M\u00e9v\u00e9lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"3","key":"483_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25(3):264\u2013296","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"483_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","volume":"9","author":"EA Innes","year":"2010","unstructured":"Innes EA (2010) Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev Vaccines 9(10):1117\u20131119","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"483_CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS (2008) Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 47(4):554\u2013566","journal-title":"Clin Infect Dis"},{"issue":"4","key":"483_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","volume":"11","author":"EY Denkers","year":"1998","unstructured":"Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11(4):569\u2013588","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"483_CR5","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.144.5.1954","volume":"144","author":"Y Suzuki","year":"1990","unstructured":"Suzuki Y, Remington J (1990) The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol 144(5):1954\u20131960","journal-title":"J Immunol"},{"issue":"11","key":"483_CR6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1017\/S0031182014000481","volume":"141","author":"E Hiszczy\u0144ska-Sawicka","year":"2014","unstructured":"Hiszczy\u0144ska-Sawicka E, Gatkowska JM, Grzybowski MM, D\u0142ugo\u0144ska H (2014) Veterinary vaccines against toxoplasmosis. Parasitology 141(11):1365\u20131378","journal-title":"Parasitology"},{"issue":"2","key":"483_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.22474","volume":"9","author":"R Verma","year":"2013","unstructured":"Verma R, Khanna P (2013) Development of Toxoplasma gondii vaccine: a global challenge. Hum Vaccin Immunother 9(2):291\u2013293","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"483_CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, F\u00f6rster-Waldl E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104(2):252\u2013266","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"483_CR9","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.ppat.0030014","volume":"3","author":"H Hajj El","year":"2007","unstructured":"El Hajj H, Lebrun M, Arold ST, Vial H, Labesse G, Dubremetz JF (2007) ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog 3(2):e14","journal-title":"PLoS Pathog"},{"issue":"5","key":"483_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.chom.2014.04.002","volume":"15","author":"RD Etheridge","year":"2014","unstructured":"Etheridge RD, Alaganan A, Tang K, Lou HJ, Turk BE, Sibley LD (2014) The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 15(5):537\u2013550","journal-title":"Cell Host Microbe"},{"issue":"3","key":"483_CR11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1073\/pnas.1313501111","volume":"111","author":"A Alaganan","year":"2014","unstructured":"Alaganan A, Fentress SJ, Tang K, Wang Q, Sibley LD (2014) Toxoplasma GRA7 effector increases turnover of immunity-related GTPases and contributes to acute virulence in the mouse. Proc Natl Acad Sci USA 111(3):1126\u20131131","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"483_CR12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/IAI.69.3.1605-1612.2001","volume":"69","author":"C Bonenfant","year":"2001","unstructured":"Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel D, Del Giudice G, Rappuoli R et al (2001) Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun 69(3):1605\u20131612","journal-title":"Infect Immun"},{"issue":"6","key":"483_CR13","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","volume":"64","author":"N Debard","year":"1996","unstructured":"Debard N, Buzoni-Gatel D, Bout D (1996) Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun 64(6):2158\u20132166","journal-title":"Infect Immun"},{"issue":"12","key":"483_CR14","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00436-015-4701-y","volume":"114","author":"MM Grzybowski","year":"2015","unstructured":"Grzybowski MM, Dziadek B, Gatkowska JM, Dzitko K, D\u0142ugo\u0144ska H (2015) Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins. Parasitol Res 114(12):4553\u20134563","journal-title":"Parasitol Res"},{"issue":"Suppl 2","key":"483_CR15","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.vaccine.2005.01.116","volume":"24","author":"J Aucouturier","year":"2006","unstructured":"Aucouturier J, Ascarateil S, Dupuis L (2006) The use of oil adjuvants in therapeutic vaccines. Vaccine 24(Suppl 2):S44\u2013S45","journal-title":"Vaccine"},{"issue":"1","key":"483_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","volume":"239","author":"MA Liu","year":"2011","unstructured":"Liu MA (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239(1):62\u201384","journal-title":"Immunol Rev"},{"issue":"22","key":"483_CR17","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2009.02.107","volume":"27","author":"AB Ismael","year":"2009","unstructured":"Ismael AB, Hedhli D, C\u00e9r\u00e8de O, Lebrun M, Dimier-Poisson I, M\u00e9v\u00e9lec MN (2009) Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii. CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection. Vaccine 27(22):2959\u20132966","journal-title":"Vaccine"},{"issue":"36","key":"483_CR18","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","volume":"23","author":"MN M\u00e9v\u00e9lec","year":"2005","unstructured":"M\u00e9v\u00e9lec MN, Bout D, Desolme B, Marchand H, Magne R, Bruneel O et al (2005) Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23(36):4489\u20134499","journal-title":"Vaccine"},{"issue":"3","key":"483_CR19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.exppara.2008.03.005","volume":"119","author":"M Xue","year":"2008","unstructured":"Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H (2008) Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Exp Parasitol 119(3):352\u2013357","journal-title":"Exp Parasitol"},{"issue":"5","key":"483_CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3024.2008.01025.x","volume":"30","author":"YL Cui","year":"2008","unstructured":"Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y (2008) Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunol 30(5):309\u2013313","journal-title":"Parasite Immunol"},{"issue":"2","key":"483_CR21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00436-007-0465-3","volume":"101","author":"J Zhang","year":"2007","unstructured":"Zhang J, He S, Jiang H, Yang T, Cong H, Zhou H et al (2007) Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice. Parasitol Res 101(2):331\u2013338","journal-title":"Parasitol Res"},{"issue":"9","key":"483_CR22","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","volume":"66","author":"V Letscher-Bru","year":"1998","unstructured":"Letscher-Bru V, Villard O, Risse B, Zauke M, Klein JP, Kien TT (1998) Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect Immun 66(9):4503\u20134506","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"483_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-4894(03)00115-2","volume":"104","author":"E Khaznadji","year":"2003","unstructured":"Khaznadji E, Boulard C, Moir\u00e9 N (2003) Expression of functional hypodermin A, a serine protease from Hypoderma lineatum (Diptera, Oestridae), in Schneider 2 cells. Exp Parasitol 104(1\u20132):33\u201339","journal-title":"Exp Parasitol"},{"issue":"11","key":"483_CR24","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/IAI.71.11.6222-6228.2003","volume":"71","author":"AB Ismael","year":"2003","unstructured":"Ismael AB, Sekkai D, Collin C, Bout D, M\u00e9v\u00e9lec MN (2003) The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 71(11):6222\u20136228","journal-title":"Infect Immun"},{"issue":"13","key":"483_CR25","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2010.01.031","volume":"28","author":"E Jongert","year":"2010","unstructured":"Jongert E, Lemiere A, Van Ginderachter J, De Craeye S, Huygen K, D\u2019Souza S (2010) Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Vaccine 28(13):2556\u20132564","journal-title":"Vaccine"},{"issue":"2","key":"483_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/S0074-02762012000200002","volume":"107","author":"H Akbar","year":"2012","unstructured":"Akbar H, Germon S, Berthon P, Dimier-Poisson I, Moir\u00e9 N (2012) Depletion of CD25+ cells during acute toxoplasmosis does not significantly increase mortality in Swiss OF1 mice. Mem Inst Oswaldo Cruz 107(2):155\u2013162","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"483_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12879-015-0815-1","volume":"15","author":"XZ Li","year":"2015","unstructured":"Li XZ, Wang XH, Xia LJ, Weng YB, Hernandez JA, Tu LQ et al (2015) Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. BMC Infect Dis 15:114","journal-title":"BMC Infect Dis"},{"issue":"38","key":"483_CR28","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","volume":"29","author":"ZG Yuan","year":"2011","unstructured":"Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ (2011) Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 29(38):6614\u20136619","journal-title":"Vaccine"},{"issue":"3","key":"483_CR29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","volume":"15","author":"MB Appaiahgari","year":"2015","unstructured":"Appaiahgari MB, Vrati S (2015) Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther 15(3):337\u2013351","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"483_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","volume":"62","author":"S Buus","year":"2003","unstructured":"Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S et al (2003) Sensitive quantitative predictions of peptide-MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach. Tissue Antigens 62(5):378\u2013384","journal-title":"Tissue Antigens"},{"issue":"5","key":"483_CR31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S et al (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12(5):1007\u20131017","journal-title":"Protein Sci"},{"issue":"48","key":"483_CR32","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2015.10.115","volume":"33","author":"MT Orr","year":"2015","unstructured":"Orr MT, Beebe EA, Hudson TE, Argilla D, Huang PW, Reese VA et al (2015) Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Vaccine 33(48):6570\u20136578","journal-title":"Vaccine"},{"issue":"2","key":"483_CR33","doi-asserted-by":"crossref","first-page":"e0148984","DOI":"10.1371\/journal.pone.0148984","volume":"11","author":"PF McKay","year":"2016","unstructured":"McKay PF, King DF, Mann JF, Barinaga G, Carter D, Shattock RJ (2016) TLR4 and TLR7\/8 adjuvant combinations generate different vaccine antigen-specific immune outcomes in minipigs when administered via the ID or IN routes. PLoS ONE 11(2):e0148984","journal-title":"PLoS ONE"},{"key":"483_CR34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biomaterials.2015.01.056","volume":"50","author":"I Dimier-Poisson","year":"2015","unstructured":"Dimier-Poisson I, Carpentier R, N\u2019Guyen TT, Dahmani F, Ducournau C, Betbeder D (2015) Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection. Biomaterials 50:164\u2013175","journal-title":"Biomaterials"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-016-0483-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T14:02:43Z","timestamp":1692540163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-016-0483-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1007\/s00430-016-0483-9","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}